- Previous Close
0.8741 - Open
0.9502 - Bid 1.7100 x 200
- Ask 1.7900 x 100
- Day's Range
0.9502 - 2.8700 - 52 Week Range
0.6250 - 9.3400 - Volume
114,903,360 - Avg. Volume
1,978,150 - Market Cap (intraday)
27.51M - Beta (5Y Monthly) 0.19
- PE Ratio (TTM)
-- - EPS (TTM)
-2.7600 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
adagiomedical.comRecent News: ADGM
View More
Performance Overview: ADGM
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ADGM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ADGM
View MoreValuation Measures
Market Cap
27.38M
Enterprise Value
23.06M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
89.59
Price/Book (mrq)
1.38
Enterprise Value/Revenue
86.68
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-79.06%
Return on Equity (ttm)
--
Revenue (ttm)
602k
Net Income Avi to Common (ttm)
-75.04M
Diluted EPS (ttm)
-2.7600
Balance Sheet and Cash Flow
Total Cash (mrq)
20.59M
Total Debt/Equity (mrq)
81.68%
Levered Free Cash Flow (ttm)
-25.6M